Capital Market Supervisory Commission No. Tor Chor 21/2551 Re: Rules on Connected Transactions and the Notification of the Board of Governors of the Stock Exchange of Thailand (SET) Re: Disclosure of

% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share

capital increase. The Board also resolved the offering of the Company’s existing shareholding in CCPT-KY of not exceed 15 % of the IPO issuance size (or equivalent to 3,525,000 ordinary shares) for the over

capital increase is finished, the Company will inform accordingly. Transaction size calculation The calculation of the transaction value is based on the financial information set out in the consolidated

method. The Disposition of Assets Transaction size is 15.00% or higher but less than 50.00%, so it is considered as the disposition of assets category 2 under the Notification of the Capital Market

capital. 7. Criteria to Determine the Value of Consideration: The total value of consideration was calculated based on SBITO’s Book Value as of September 30, 2017 which is SBITO’s latest audited financial

transaction : Relating to assets or services  Item size : 9,000,000 THB Transaction is considered as related transaction according to Notification of Capital Market Commission as the category of assets or

this regards, the company will hold 62,500 ordinary shares of All S, or 6.25% of its registered capital, par value of 100 baht per share, total amount of 6,250,000 baht. The transaction size is

After investment : 33 percent of the total issued and paid up capital of Thippayabadin Co.,Ltd. (registered capital 450 million baht) The name of shareholders after Ramkhamhaeng take part in Thippayabadin

Maleenont, who is the director and the major shareholder of the Company (“Transaction”). The disposal of shares of TSE pursuant to the Notification of Capital Market Supervisory Board No. Tor. Jor. 20/2551 Re